Back to search results

Pre-surgery laxatives for robotic urologic surgery

This study is looking at whether taking polyethylene glycol 3350 (a type of laxative, like Miralax) before robotic urologic surgery can help patients recover their normal bowel function faster. Many people experience constipation and stomach issues after these surgeries. You might be able to join if you are 30 to 100 years old and are having robotic surgery for prostate cancer or kidney cancer. The study aims to see if patients who take the laxative have their first bowel movement sooner after surgery, measured within 7 days. The current recruitment status is unclear, but the study plans to enroll 240 participants.

Study design
This study is comparing two groups of patients: one group will take polyethylene glycol 3350 before surgery, and the other group will not. It plans to include 240 participants.
What's involved
Patients in the intervention group will take polyethylene glycol 3350 for three days before their robotic urologic surgery.
Compensation
Not stated in the trial record.
Follow-up
The main outcome of the study is measured at 7 days after surgery, focusing on the time to your first bowel movement.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT05805436

Preop Laxatives in Robotic Urologic Surgery

Recruiting
PHASE4Ages 30+InterventionalTreatment
Chad R. Tracy
~240 participants
Updated 2025-05-30 on ClinicalTrials.gov
What's tested:Polyethylene Glycol 3350

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Time to first bowel movement after surgery
Measured over 7 days

Conditions

Prostate Cancer
Kidney Cancer
Constipation

Explore related trials

Kidney CarcinomaProstate Carcinoma

NCT05805436

Where you'd take part

This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • University of Iowa Hospitals & Clinics

    Iowa City, Iowano site contact published

    Recruiting

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

Who to contact

Chad Tracy, MD
[email protected]
+1 319 335 8056
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Patients 30 years or older undergoing robotic-assisted laparoscopic radical prostatectomy, transperitoneal radical nephrectomy, or transperitoneal partial nephrectomy

Exclusion

Patients under 30 years old
Patients with a contraindication to receiving polyethylene glycol or other forms of laxatives
People who regularly take Miralax
Patients undergoing retroperitoneal radical or partial nephrectomy
Patients with severe ulcerative colitis or Crohn's disease
Patients with intestinal diversions (colostomy, ileostomy)
Patients with prior abdominal or pelvic radiation
Patients who will not follow up with UIHC postoperatively
Patients who are incarcerated

What this trial measures

  • Time to first bowel movement after surgery7 days

    Time to first bowel movement after surgery